Ranidin 300 mg (Tablet)
Unit Price: ৳ 4.03 (10 x 10: ৳ 403.00)
Strip Price: ৳ 40.30
Medicine Details
| Category | Details |
|---|---|
| Generic | Ranitidine hydrochloride |
| Company | Acme laboratories ltd |
| Also available as |
Title and Categories
- Ranidin
- Medicine
- Gastrointestinal Medication
Dosage
- 150 mg tablet
- 300 mg tablet
- Syrup
- Duodenal and gastric ulcer treatment
- Reflux oesophagitis treatment
- Zollinger Ellison syndrome treatment
- Episodic dyspepsia treatment
- Maintenance therapy
- Peptic ulcer treatment in children
- IV injection
- IV infusion
- Intramuscular injection
- Prophylaxis of haemorrhage from stress ulceration
- Prophylaxis of recurrent haemorrhage in patients bleeding from peptic ulceration
- Prophylaxis of upper gastrointestinal haemorrhage from stress ulceration
- Dosing for children
Indications
- Active duodenal ulcer treatment
- Benign gastric ulcer treatment
- Ulcer treatment and prevention associated with non-steroidal anti-inflammatory agents
- Post operative stress ulcer treatment
- Zollinger-Ellison Syndrome treatment
- GERD treatment
- Gastrointestinal haemorrhage treatment
- Recurrent haemorrhage treatment
- Before general anesthesia in patients at risk of acid aspiration
- Preventing recurrences
Pharmacology
- Competitive blocking of histamine at H2-receptors
- Inhibition of gastric acid secretion
- No effect on pepsin secretion, pentagastrin-stimulated intrinsic factor secretion or serum gastrin
Interaction
- Delayed absorption and increased peak serum concentration with propantheline bromide
- Minimal inhibition of hepatic metabolism of certain drugs
- Alteration of absorption of pH-dependent drugs
- Reduced bioavailability with antacids
Contraindications
- Hypersensitivity to Ranitidine
Side Effects
- Altered bowel habit
- Dizziness
- Rash
- Tiredness
- Reversible confusional states
- Headache
- Decreased blood counts
- Muscle or joint pain
Pregnancy and Lactation
- Crosses the placenta
- Excretion in human breast milk
- Caution during nursing
Precautions and Warnings
- Reduced dosage for patients with impaired renal and hepatic function
Use in Special Populations
- Elderly patients
Overdose Effects
- Specific in action with no particular expected problems following overdosage
- Symptomatic and supportive therapy
- Possible removal by haemodiaiysis
Therapeutic Class
- H2 receptor antagonist
Reconstitution
- Dilution for slow IV injection
- Dilution for intermittent slow IV infusion
- Dilution for continuous IV infusion
- Dilution for hypersecretory conditions
Storage Conditions
- Cool and dry place
- Protection from light